Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. The company started manufacturing analytical instrumentation based on a patented capacitively coupled plasma emission technology.The organization develops laboratory solutions, analytical instrumentation, and automated liquid handling platforms. [mepr-show rules=”18700″ unauth=”message”]
Aurora Biomed developed its anitbody COVID-19 IgM/IgG Rapid Test Kit which can measure results in 10-15 minutes. The test uses Human serum, plasma, or whole blood and can be administered at home or under the supervision of medical personel. It is currently in development and price is available upon request.
Aurora is a privately owned company and in 2000, Aurora became the first to develop a non-radioactive, label-free technology for the study and high throughput screening of ion channel and transporter targets. This technology has been rapidly incorporated into many pharmaceutical drug discovery pipelines and academic labs. Aurora expanded its products to include the VERSA series of automated liquid handling platforms aimed at the life science, molecular diagnostics, and precision medicine fields. In 2007, Aurora Biomed opened its Asia sales and services centre to facilitate expansion into the rapidly growing Asia market. To further expand Aurora’s market reach, an active network of distributors based in over 80 countries worldwide, providing sales and service support to customers, was developed.
Additional Resources:
[/mepr-show]